Stay informed with the latest news from the Philippines and around the world. Get updates on local and breaking news, explore odd and unique stories, read opinions and analyses, and view captivating news photos and videos.
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Fertility Issues in Young People and Adults with Cancer
Learn how cancer treatment can affect fertility and ways that fertility can be preserved. The updated pages Fertility Issues in Girls and Women and Fertility Issues in Boys and Men also include sample questions to ask your doctor and tips on how to find financial resources and clinical trials.
People with cancer who have depression, pain, and fatigue are often referred to providers for treatment and must follow up to make an appointment. A recent study showed that integrating the assessment and treatment of symptoms as part of routine care may help them better manage these problems.
In a new study involving nearly 1,000 people, a liquid biopsy accurately detected early- and late-stage pancreatic cancer. When paired with a test for the protein CA19-9, the combination accurately identified 97% of people with early-stage disease.
The Food and Drug Administration (FDA) has approved the targeted therapy alectinib for ALK-positive non-small cell lung cancer. Results from a large clinical trial showed that those treated with alectinib after surgery lived longer without their cancer coming back than those treated with chemotherapy, the current standard treatment.
FDA has approved the targeted therapy tovorafenib (Ojemda) for children aged 6 months and older who have a type of brain tumor called glioma. This approval is for slow-growing (low-grade) tumors that have an abnormal BRAF gene and have come back or did not respond to other treatment.
This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment